Comparator choices in pharmacoepidemiology studies of Alzheimer's disease

Nat Aging. 2023 Jul;3(7):791-792. doi: 10.1038/s43587-023-00417-x. Epub 2023 May 22.

Authors

Qoua L Her¹, Jacob C Kahrs², Til Stürmer²

Affiliations

¹ Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. qouaher@email.unc.edu.
² Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

PMID: 37217663
DOI: 10.1038/s43587-023-00417-x

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Alzheimer Disease* / drug therapy
Humans
Pharmacoepidemiology

Grants and funding